Basics Tevogen Bio Holdings Inc. Common Stock IPO Date: February 15, 2024 Sector: Healthcare Industry: Biotech Market Cap: $79.6M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 5.79% Avg Daily Range (30 D): $0.03 | 5.45% Avg Daily Range (90 D): $0.03 | 3.99% Institutional Daily Volume Avg Daily Volume: 2.63M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 311 Avg Trade Size (Sh.) (30 D): 324 Avg Trade Size (Sh.) (90 D): 313 Institutional Trades Total Inst.Trades: 4 Avg Inst. Trade: $.83M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.86M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 913.51K     News Nov 3, 2025 @ 7:45 PM Tevogen Clarifies Reported Financials, Highlightin... Source: Kirti Desai (Cfo) Oct 15, 2025 @ 7:50 PM Tevogen Updates on TVGN 489 Following Growing Long... Source: Dr. Ryan Saadi Sep 19, 2025 @ 7:40 PM Tevogen Commends HHS for Addressing Long COVID, Em... Source: Tevogen Bio Holdings Inc. Aug 18, 2025 @ 9:50 PM Tevogen CEO Donates Personal Shares to Support Loc... Source: Dr. Ryan Saadi Aug 12, 2025 @ 3:09 PM Healthcare AI Market Explodes 38.5% Annually as Di... Source: Prnewswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.03 $-.03 $-.07 Diluted EPS $-.03 $-.03 $-.07 Revenue $ -.06M $ -.04M $ M Gross Profit $ $ $ Net Income / Loss $ -5.73M $ -5.5M $ -10.37M Operating Income / Loss $ -5.73M $ -5.44M $ -10.36M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio